Spurious pleocytosis.
Mathai
Susanna
S
Northern Centre for Cancer Care, Freeman Hospital.
Jones
Gail L
GL
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D016477:Artifacts; D003561:Cytarabine / Q000008:administration & dosage / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D003951:Diagnostic Errors; D004337:Drug Carriers; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D007964:Leukocytosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008081:Liposomes / Q000008:administration & dosage / Q000648:ultrastructure*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000134:cerebrospinal fluid* / Q000150:complications / Q000188:drug therapy; D008581:Meningitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D010316:Particle Size
D000964:Antimetabolites, Antineoplastic; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008081:Liposomes; D003561:Cytarabine